Deniz Kent, co-founder and CEO of Prolific Machines, has raised over $90M from top investors for his biotech company.
Deniz Kent, co-founder and CEO of Prolific Machines, has raised over $90M from top investors for his biotech company. He discusses pivoting his company and the importance of raising capital when it is not critically needed to maximize leverage and terms.
So, we're talking here about what what you want, but I want to talk about what you don't want, you know, and and in that case, you know, what are you afraid of, Dennis? I'm really curious to hear your response on this one. I think there's a couple of things I'm afraid of. One is that with any new technology that is powerful like this, it can be used for good and it can be used for ill. Um, making sure that it doesn't get into the wrong hands and used for things that are not good. I think that's one of